News

Clinical Manifestations and Evaluation of Postmenopausal Vulvovaginal Atrophy

Link: https://www.tandfonline.com/doi/full/10.1080/09513590.2021.1931100

The ISSVD Vaginitis and Microbiome Committee Subcommittee on vaginal atrophy has published a manuscript titled Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy. It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving various pharmacological or endocrine treatments or radiotherapy.

Faustino R. Pérez-López, Pedro Vieira-Baptista, Nancy Phillips, Bina Cohen-Sacher, Susana C. A.V. Fialho & Colleen K. Stockdale (2021): Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.Gynecological Endocrinology, DOI: 10.1080/09513590.2021.1943346

Back to all news